医学与哲学
醫學與哲學
의학여철학
MEDICINE AND PHILOSOPHY
2015年
10期
26-28
,共3页
李聪%李明%韩杰%孙大勇%雷阳%张炳蔚
李聰%李明%韓傑%孫大勇%雷暘%張炳蔚
리총%리명%한걸%손대용%뢰양%장병위
脑梗死%动脉粥样硬化%性别%尤瑞克林
腦梗死%動脈粥樣硬化%性彆%尤瑞剋林
뇌경사%동맥죽양경화%성별%우서극림
cerebral infarction%atherosclerosis%gender%urinary kallidinogenase
探讨尤瑞克林对不同性别动脉粥样硬化性血栓性脑梗死患者的临床疗效。选取动脉粥样硬化性血栓性脑梗死患者60例,观察不同性别的患者选用尤瑞克林治疗与一般治疗的疗效对比。结果显示,尤瑞克林治疗组女性患者NIHSS评分改善明显强于一般治疗组女性患者(P<0.05);尤瑞克林治疗组的显效率明显高于一般治疗组,差异有统计学意义(P<0.05);尤瑞克林治疗组女性患者的显效率明显高于男性患者(P<0.05)。因此尤瑞克林可以显著改善动脉粥样硬化性血栓性脑梗死的临床预后,特别是女性患者的临床预后。
探討尤瑞剋林對不同性彆動脈粥樣硬化性血栓性腦梗死患者的臨床療效。選取動脈粥樣硬化性血栓性腦梗死患者60例,觀察不同性彆的患者選用尤瑞剋林治療與一般治療的療效對比。結果顯示,尤瑞剋林治療組女性患者NIHSS評分改善明顯彊于一般治療組女性患者(P<0.05);尤瑞剋林治療組的顯效率明顯高于一般治療組,差異有統計學意義(P<0.05);尤瑞剋林治療組女性患者的顯效率明顯高于男性患者(P<0.05)。因此尤瑞剋林可以顯著改善動脈粥樣硬化性血栓性腦梗死的臨床預後,特彆是女性患者的臨床預後。
탐토우서극림대불동성별동맥죽양경화성혈전성뇌경사환자적림상료효。선취동맥죽양경화성혈전성뇌경사환자60례,관찰불동성별적환자선용우서극림치료여일반치료적료효대비。결과현시,우서극림치료조녀성환자NIHSS평분개선명현강우일반치료조녀성환자(P<0.05);우서극림치료조적현효솔명현고우일반치료조,차이유통계학의의(P<0.05);우서극림치료조녀성환자적현효솔명현고우남성환자(P<0.05)。인차우서극림가이현저개선동맥죽양경화성혈전성뇌경사적림상예후,특별시녀성환자적림상예후。
To evaluate the efficacy and deficiency of urinary kallidinogenase acts on different gender atherosclerotic thrombotic cerebral infarction .Sixty different gender atherosclerotic thrombotic cerebral infarction patients were compared by the efficacy of urinary kallidinogenase treatment and general treatment .The reduction of NIHSS score was significantly higher in the female patients treated by urinary kallidinogenase than the others .The significant efficiency of the urinary kallidinogenase treatment group was higher than the general treatment group and the significant efficiency of the female patients treated by urinary kallidinogenase was higher than the male patients .Therefore ,the urinary kallidinogenase can significantly improve the clinical outcome of patients with atherosclerotic thrombotic cerebral infarction ,especially the female patients .